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Abstract
Previous studies have shown that ethanol exposure causes apoptosis in cranial neural crest cells
(NCCs), an ethanol-sensitive cell population implicated in Fetal Alcohol Spectrum Disorders
(FASD). Additionally, induction of endogenous antioxidants through activation of nuclear factor-
erythroid 2-related factor 2 (Nrf2) has been shown to prevent oxidative stress and apoptosis in
ethanol-exposed mouse embryos. The objective of this study was to test whether tert-
butylhydroquinone (tBHQ), an Nrf2 inducer, can protect NCCs against ethanol-induced apoptosis.
Ethanol exposure was shown to cause a moderate increase in the protein expression of Nrf2 and its
downstream antioxidants in the NCCs. Treatment of NCCs with tBHQ alone significantly
increased the protein expression of Nrf2 and its downstream antioxidants and also significantly
increased the activities of the antioxidant enzymes. In NCCs exposed to ethanol, the tBHQ-
mediated antioxidant response prevented oxidative stress and apoptosis. These results clearly
demonstrate that activation of Nrf2 signaling confers protection against ethanol-induced apoptosis
in NCCs.
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1. Introduction
Prenatal alcohol (ethanol) exposure results in a range of structural and functional birth
defects. These comprise the Fetal Alcohol Spectrum Disorder (FASD), with full-blown Fetal
Author to whom correspondence should be sent: Shao-yu Chen, Ph.D., Department of Cancer Biology and Pharmacology, University
of Illinois College of Medicine at Peoria, Peoria, IL 61605-2576, Phone: 1- (309) 671-8538, FAX: 1- (309) 671-8403,:
sychen@uic.edu.
Disclosure Statement
The authors declare that there are no conflicts of interest.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Biochem Pharmacol. Author manuscript; available in PMC 2011 July 1.
Published in final edited form as:













Alcohol Syndrome (FAS) representing the severe end of the spectrum. Notably, prenatal
alcohol exposure is considered to be the leading known cause of mental retardation in the
Western world [1;2].
There are a number of factors that contribute to the genesis of the birth defects that ethanol
causes, including the vulnerability of selected cell populations to ethanol-induced
cytotoxicity [3–7]. As shown using rodent and avian animal models, among the vulnerable
cell populations are cranial neural crest cells (NCCs) [3;5;8–10]. NCCs are progenitors of
multiple cell types, including the skeletal and connective tissues of the face [11–13]. Ethanol
has been shown to diminish NCC populations via the induction of apoptosis, a result that
appears to contribute heavily to subsequent facial abnormalities [3;5;6;8;10].
Substantial evidence supports a critical role for oxidative stress in ethanol-induced apoptosis
and subsequent malformations [8;14–17]. Reactive oxygen species (ROS) generation has
been observed in mouse embryos exposed to ethanol both in vitro and in vivo [15;17] with
various embryonic cell populations, including NCCs, being involved [8;14;18;19]. These
findings provided a framework for studies employing exogenous antioxidants to reduce
ethanol’s teratogenicity. In this regard, superoxide dismutase (SOD) has been shown to
diminish ethanol-induced superoxide anion generation, lipid peroxidation and cell death, as
well as the incidence of neural tube defects in cultured mouse embryos [17]. In vivo studies
have also shown that, in mice, maternal treatment with an SOD and catalase mimetic,
EUK-134, reduces ethanol-induced apoptosis in selected cell populations in the developing
limb buds and subsequent limb defects [20]. However, while promising for human
application, exogenous antioxidants alone are not as effective in reducing ethanol’s
teratogenicity as desirable.
Another strategy for prenatal protection from ethanol-induced oxidative injury entails
chemically mediated upregulation of endogenous antioxidants. In this light, recently, Nrf2
has been demonstrated to be a critical transcription factor that regulates the induction of
phase 2 detoxifying and antioxidant genes [21;22]. Under basal conditions, Nrf2 is anchored
mainly in the cytoplasm through binding to Kelch-like ECH-associated protein 1 (Keap1),
which in turn facilitates the ubiquitylation and subsequent proteolysis of Nrf2. When
challenged by oxidative stress, Nrf2 dissociates from Keap1 and translocates into the
nucleus where it forms a heterodimer with its partner, Maf and elicit the antioxidant
response by induction of a battery of gene products, including antioxidant genes and phase II
detoxification enzymes [23;24]
A wide range of natural and synthetic small molecules with diverse chemical backgrounds
are potent inducers of Nrf2 activity [25–27]. Among these Nrf2 inducers are
isothiocyanates, 1,2-dithiole-3-thiones (D3T) and tert-butylhydroquinone (tBHQ) [27–29].
Of these, tBHQ, which is approved for human use, is of particular interest. It is a metabolite
of the widely used food antioxidant butylated hydroxyanisole that increases Nrf2 protein
stability through inhibition of the Keap1-mediated ubiquitination [30–32]. It has been
suggested that tBHQ directly acts on the thiol group of Keap1 by a C151-dependent
mechanism [33].
Using an in vivo FASD model, recent studies have shown that maternal ethanol treatment
increases both Nrf2 protein levels and Nrf2-ARE binding in mouse embryos. Ethanol
exposure also resulted in a moderate increase in the mRNA expression of Nrf2 downstream
target detoxifying and antioxidant genes as well as an increase in the expression of
antioxidant proteins. Pretreatment with the Nrf2 inducer, D3T, significantly increased Nrf2
protein levels and Nrf2-ARE binding, and strongly induced the mRNA expression of Nrf2
downstream target genes. In addition, maternal D3T pretreatment resulted in a significant
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decrease in ethanol-induced ROS generation and apoptosis in the embryos [15]. These
results demonstrate that Nrf2 signaling is involved in induction of an antioxidant response in
ethanol-exposed mouse embryos.
While the studies of intact embryos have contributed significantly to our base of knowledge
regarding Nrf2 activation in mouse embryos following ethanol exposure, for a more
complete understanding of the role Nrf2 signaling in ethanol-induced teratogenesis, studies
focused on vulnerable cell populations are needed. To this end, the current study employed
cultured NCCs to elucidate the molecular mechanisms involved in ethanol-induced Nrf2
activation in NCCs, and to determine whether the Nrf2 inducer, tBHQ, can provide
protection against ethanol-induced oxidative stress and apoptosis in NCCs.
2. Materials and methods
2.1. Animal care
C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME, USA) were mated for 2 h early
in the light cycle. The time of vaginal-plug detection was considered 0 days, 0 h of gestation
(GD 0:0). Mice were maintained on an ad libitum diet of breeder chow and water. Pregnant
mice were killed on GD 10.5. The embryos were removed from the uterus and processed for
NCC culture as described below. All protocols used in this study were approved by the
University of North Carolina at Chapel Hill Institutional Animal Care and Use Committee.
2.2. Primary NCC culture
NCC cultures were established according to the methods of Zhao et al [34] with
modification. Briefly, embryos collected on gestational day10.5 (GD10.5) were placed in a
Petri dish containing Dulbecco’s Phosphate Buffered Saline (DPBS). From each embryo, the
first branchial arches were dissected and digested at 37°C in DPBS with 0.05% collagenase
(Sigma, St. Louis, MO, USA). The first arch tissue was pipetted up and down to yield a
single cell suspension. The cells were washed with fresh culture medium to stop digestion
and were then plated onto fibronectin coated 6-well plates and maintained in Dulbecco’s
Modified Eagle Medium (DMEM) with Chicken Embryo Extract at 37°C in 5% CO2/95%
air. The cells were used for experiments when they reached 70% confluence.
2.3. Ethanol exposure and tBHQ treatment
For ethanol exposure, NCCs were cultured in the presence of 100 mM ethanol (Sigma, St.
Louis, MO, USA) for 24 hours. This ethanol concentration was chosen because previous
studies have shown that at early developmental stages in mice, acute administration of
ethanol that yields peak maternal blood ethanol concentrations of 400–500 mg/dL
(approximately 85–105 mM) is required to induce excessive cell death and subsequent
malformations that are characteristic of FAS [4,5,10]. Although this ethanol concentration is
high, it is not beyond that which can, and does occur in chronic alcoholics [35]. Evaporation
of ethanol was prevented by tightly sealing the culture plates with Optical Tape (Bio-Rad
Laboratories, Inc., Hercules, CA, USA). Parallel cultures of control cells were treated in the
same manner as the ethanol-exposed cells with respect to sealing of the culture plates. For
tBHQ treatment, NCCs were incubated with 10 μM tBHQ (Sigma, St. Louis, MO, USA)
alone for 16 hours, followed by 24 hours of concurrent exposure to tBHQ and 100 mM
ethanol. The concentration of tBHQ used in the present study was based on the efficacy of
tBHQ as established in cell culture systems by other investigators [28;31].
2.4. Western blotting
Western blots were performed as described previously [15]. Briefly, NCCs were washed
once in phosphate-buffered saline (PBS) and lysed for 30 min in RIPA lysis buffer (PBS, 0.5
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% Sodium Deoxycholate, 1 % NP-40, 0.1 % SDS, 1 mM Dithiothreitol) with 1 mM PMSF
and protease cocktail inhibitors (Roche Applied Science, Indianapolis, IN, USA). The
samples were centrifuged at 16,000 g for 10 min at 4 °C. The collected supernatants were
then used for Western blotting. The protein concentration in each sample was determined
using Bio-Rad Protein Assay Reagent (Bio-Rad Laboratories, Inc., Hercules, CA, USA)
according to the manufacturer’s instructions. Western blots were performed by standard
protocols. The levels of Nrf2, catalase, and SOD1 and SOD2 proteins were analyzed with
the following antibodies, respectively: rabbit polyclonal anti-Nrf2 IgG (1:500, Santa Cruz,
Santa Cruz, CA, USA), mouse monoclonal anti-catalase antibody (1:500; Sigma, St. Louis,
MO, USA), rabbit polyclonal anti-SOD1 IgG (1:1,000; Assay Designs, Ann Arbor, MI,
USA), and rabbit polyclonal anti-SOD2 IgG (1:500; Assay Designs, Ann Arbor, MI, USA).
The membranes were scanned on a Bio-Rad Versa DocTM Imaging System (Model 4000)
and the intensity of the protein bands was analyzed using Bio-Rad Quantity One software
(Version 4.5.1).
2.5. Measurement of antioxidant enzyme activities
The activities of antioxidant enzymes were determined as described previously [15]. Total
superoxide dismutase (SOD) activity was measured with an SOD Assay Kit from Dojindo
Molecular Technologies, Inc. (Gaithersburg, MD, USA) according to the manufacturer’s
instruction. Catalase activity was determined with an Amplex Red Catalase Assay Kit
(Molecular Probes, Eugene, OR, USA) according to the manufacturer’s protocol.
2.6. Measurement of ROS generation
ROS generation was measured using a 2′,7′-dichlorodihydro-fluoroscein diacetate
(DCHFDA) assay as described previously [15]. Briefly, the NCCs were washed twice in
assay buffer (130 mM KCl, 5 mM MgCl2, 20 mM NaH2PO4, 20 mM Tris-HCl, 30 mM
glucose) and then homogenized in 100 μl of the buffer. The homogenate was centrifuged at
10,000 g for 15 min at 4°C and the supernatant, which was equivalent to 40 μg of protein,
was transferred to a 96-well micro-plate. Assay buffer and 2 μl of 2′,7′-dichlorodihydro-
fluoroscein diacetate (DCHFDA; Molecular Probes Inc., Eugene, OR, USA) (5 mM in
DMSO) were added to the micro-plate to give a total reaction volume of 200 μl. The
samples were incubated at 37°C for 15 min. The fluorescence intensity was monitored for 30
min after excitation at 485 nm and emission at 535 nm using a CytoFlor fluorescence plate
reader (Perseptive Biosystems, Foster City, CA, USA). The protein concentration was
measured using Bio-Rad Protein Assay Reagent (Bio-Rad Laboratories, Inc., Hercules, CA,
USA) according to the manufacturer’s instructions. The ROS levels were expressed as
relative fluorescence intensity units.
2.7. Flow-Cytometric Analysis of Apoptosis
Determination of apoptosis was performed using an Annexin V –FITC Apoptosis Detection
Kit (BD Bioscience, San Jose, CA, USA) according to the manufacturer’s instructions. In
brief, NCCs were washed twice with cold PBS and then resuspended in 1X Binding Buffer
at a concentration of 1 × 106 cells/ml. Then 100 μl of the solution (1 × 105 cells) was
transferred to a 5 ml culture tube and 5 μl of Annexin V was added. The cells were
incubated for 15 min at room temperature in the dark and then analyzed in a Dako CyAn
flow cytometer (Beckman-Coulter Dako CyAn ADP).
2.8. Statistical analysis
Statistical analyses were performed by using StatView software (SAS Institute Inc, Cary,
NC). Data are expressed as mean ± SEM of three separate experiments. Statistical
comparisons between groups were analyzed by a One-way ANOVA. Multiple comparison
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post-tests between groups were conducted by using Bonferroni’s test. Differences between
groups were considered significant at p < 0.05.
3. Results
3.1. Ethanol exposure and treatment with tBHQ significantly increased Nrf2 protein
expression in NCCs
To determine whether ethanol exposure and treatment with tBHQ can induce Nrf2
expression in NCCs, Nrf2 protein level was examined in NCCs that were exposed to ethanol
or tBHQ alone, or in combination. Western blot analysis revealed an increase in the level of
Nrf2 protein in NCCs exposed to ethanol or tBHQ alone. As illustrated in Fig. 1, NCCs
treated with 10 μM tBHQ alone showed a 2.8 fold increase in Nrf2 protein expression as
compared to control cultures. Exposure to 100 mM ethanol for 24 hours also increased Nrf2
protein expression, though to a lesser extent. The combination of the tBHQ treatment and
ethanol exposure yielded a 4.5 fold increase in Nrf2 protein expression in NCCs as
compared to the control group.
3.2. tBHQ treatment significantly increased antioxidant protein expression in ethanol-
exposed NCCs
Western blot analysis was also performed to examine whether overexpression of Nrf2
protein is accompanied by increased expression of Nrf2 downstream antioxidant proteins in
this model system. Exposure to ethanol alone was found to increase the expression of
cytoplasmic superoxide dismutase (SOD1), mitochondrial superoxide dismutase (SOD2)
and catalase. However, for each of these antioxidants, less than a 1-fold change occurred.
This result is consistent with that of previous in vivo studies that have shown that ethanol
can only induce a moderate increase in antioxidant protein expression in mouse embryos
treated with ethanol [15]. In contrast, treatment with tBHQ alone, or along with ethanol,
significantly increased the protein expression of SOD1, SOD2 and catalase. The expression
of SOD1 and catalase was increased 3.0 and 4.4 fold, respectively, in the co-treated NCCs as
compared to controls (Figs. 2–3).
3.3. Treatment with tBHQ increased the activity of the antioxidant enzymes, SOD and
catalase, in NCCs
The activities of SOD and catalase were analyzed to test whether upregulation of Nrf2 by
ethanol or tBHQ results in an increase in the catalytic activity of antioxidant enzymes in
NCCs. As shown in Fig. 4, while ethanol exposure alone resulted in increased SOD and
catalase activity, treatment with tBHQ in combination with ethanol resulted in significantly
greater increases in the activities of these enzymes, confirming the corresponding changes in
the activities of major antioxidant enzymes that accompany protein induction.
3.4. tBHQ treatment significantly reduced ROS generation in ethanol-exposed NCCs
To test whether activation of Nrf2 and induction of Nrf2 downstream antioxidant proteins
reduce ethanol-induced oxidative stress in NCCs, a 2′,7′-dichlorodihydro-fluoroscein
diacetate (DCHFDA) assay was used. The results of these experiments confirmed previous
findings showing that ethanol exposure significantly increases ROS generation in NCCs. As
expected, treatment with tBHQ was found to significantly reduce the ethanol-induced ROS
generation (Fig. 5).
3.5. Treatment with tBHQ significantly reduced ethanol-induced apoptosis in NCCs
With the above findings and recognizing that ethanol-induced excessive NCC apoptosis is a
prominent pathogenic feature in FASD models, the potential of tBHQ-mediated Nrf2-
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dependent antioxidant response to diminish this endpoint was tested. As shown in Fig. 6,
flow cytometric analysis revealed a significant increase in apoptosis in the ethanol-exposed
NCCs as compared to controls. tBHQ treatment significantly reduced the ethanol-induced
apoptosis.
4. Discussions
The results of this study show that in vitro exposure of a vulnerable embryonic cell type,
NCCs, to teratogenic ethanol concentrations increases the protein expression of Nrf2. It also
increases the protein expression and catalytic activity of Nrf2’s downstream antioxidants,
SOD and catalase. These results provide support for the hypothesis that Nrf2 signaling is
involved in the induction of antioxidant response in ethanol-exposed mouse embryos.
Importantly, they also, demonstrate that Nrf2 activation and Nrf-2 dependent antioxidant
response can be induced in NCCs, an ethanol-sensitive cell population implicated in FASD.
The central role of Nrf2 in cell survival has been well established by over a decade of
research. Kotlo et al [36] found that over-expression of Nrf2 protected cell from Fas-induced
apoptosis. Activation of Nrf2 was also found to protect against cell death in an in vitro
model of ischemia/reperfusion [37]. Additionally, nitric oxide-induced apoptosis can be
prevented by the activation of Nrf2 [38]. Data have also shown that in response to elevated
chromium (VI) and cadmium, mouse embryonic fibroblast cells lacking Nrf2 exhibit
increased ROS production and apoptosis [39;40]. However, in this study, even though the
activity of Nrf2 downstream antioxidants was increased following ethanol exposure, more
than 1-fold increases in NCC apoptosis were observed. This may be accounted for by the
fact that the observed Nrf2, SOD and catalase changes were moderate. These findings are
consistent with a previous in vivo study showing that the increases in the protein expression
of Nrf2, SOD and catalase in mouse embryos exposed to ethanol alone are moderate [15], as
well as with previous reports illustrating ethanol-induced apoptosis and subsequent
abnormal development of involved tissues [4;5;20]. These results indicate that the ethanol-
induced activation of Nrf2 and its downstream antioxidants is an adaptive response that is
insufficient to prevent ethanol-induced apoptosis. In contrast, a chemical inducer of Nrf2,
D3T, has been shown to potently increase Nrf2 levels, induce Nrf2 downstream antioxidant
and detoxifying gene expression and prevent apoptosis in ethanol exposed embryos [15].
In addition to D3T, tBHQ has long been of interest as effective inducer of Nrf2 [22;33;41].
Studies have shown that tBHQ treatment increases Nrf2 activation in both in vivo and in
vitro systems [28;31–33]. In vitro studies have shown that tBHQ treatment augments ARE-
dependent gene expression in cultured astrogytes and protects neurons from oxidative injury
[41–43]. There is abundant evidence that tBHQ is effective in diminishing ROS-mediated
damage as a result of its action on Nrf2 [44;45]. Lee et al [46] observed a protective effect of
tBHQ against oxidative stress in wild-type astrocytes. This did not occur in Nrf2-deficient
cells. They also found that 98% of tBHQ-inducible Nrf2-dependent genes in wild-type cells
were not altered in Nrf2-null astrocytes. Other studies have shown that in Nrf2−/− mice the
protective effect of tBHQ on mitochondrial stress was lost [47]. Additionally, microarray
analyses of tBHQ-induced gene expression have indicated that the majority of identified
genes in glia and neurons are Nrf2 dependent [41]. Consistent with these studies, the current
results show that treatment of ethanol-exposed NCCs with tBHQ led to a significant
induction of Nrf2 and an increased expression of antioxidant proteins and enzyme activity.
tBHQ treatment also significantly reduced ethanol-induced ROS generation and NCC
apoptosis. These results clearly demonstrate that the Nrf2 inducer, tBHQ, can induce an
antioxidant response and prevent oxidative stress and apoptosis in ethanol-exposed NCCs.
However, it is noteworthy that while tBHQ treatment resulted in a 3 to 4-fold increase in
SOD and catalase protein expression in NCCs, tBHQ-induced increases in SOD and catalase
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activities were relatively moderate. It appears that the modest increases in SOD and catalase
activities alone might not fully explain the robust anti-apoptotic action of tBHQ. This
suggests that other antioxidants induced by Nrf2, which can induce a wide spectrum of
antioxidants, may also contribute to tBHQ’s antioxidant and anti-apoptotic actions. In
addition, other protective actions of tBHQ which have not yet identified may be involved in
its anti-apoptotic effects.
Although FASD can be completely prevented by not drinking any alcohol during pregnancy,
given the difficulties in achieving this goal, it is important to discover practical therapeutic
approaches to prevent FASD. The results of this study add to the growing evidence that
antioxidant supplementation can prevent ethanol induced damage or pathogenesis in certain
experimental models of fetal alcohol exposure. The potency of tBHQ in inducing Nrf2
activation and preventing ethanol-induced oxidative stress and apoptosis in NCCs, along
with the fact that tBHQ is a metabolite of a widely used food antioxidant which is approved
for human use makes tBHQ a promising therapeutic agent for human FASD.
In conclusion, the results of the current study demonstrate that Nrf2 activation and Nrf-2
dependent antioxidant response can be induced in NCCs, an ethanol-sensitive cell
population implicated in FASD and that tBHQ-mediated antioxidant response can prevent
ethanol-induced oxidative stress and NCC apoptosis. These findings provide insights into
the regulatory mechanisms involved in the induction of antioxidant response in ethanol-
exposed embryonic cells and provide a new therapeutic perspective for FASD that is based
on transcriptional modulation.
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Treatment with ethanol, tBHQ, and a combination of these agents increased the level of
Nrf2 protein in NCCs. Western blot was performed to analyze the level of Nrf2 protein. Cell
lysates were prepared from NCCs cultured in control medium (Control), treated with 100
mM ethanol (EtOH) or 10 μM tBHQ (tBHQ) alone, or treated with both ethanol and tBHQ
(EtOH + tBHQ). Data are expressed as fold change over control and represent the mean ±
SEM of three separate experiments. *p < 0.05 vs. control. # p< 0.05 vs. EtOH.
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Treatment with ethanol and tBHQ increased the SOD protein expression in NCCs. Western
blot was performed to analyze the level of SOD protein in neural crest cells. Cell lysates
were prepared from NCCs cultured in control medium (Control), treated with 100 mM
ethanol (EtOH) or 10 μM tBHQ (tBHQ) alone, or treated with both ethanol and tBHQ
(EtOH + tBHQ). Data are expressed as fold change over control and represent the mean ±
SEM of three separate experiments. *p< 0.05 vs. control. # p< 0.05 vs. EtOH.
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tBHQ treatment resulted in significantly increased catalase protein expression in NCCs.
Western blot was performed to analyze the level of catalase protein in NCCs. Cell lysates
were prepared from NCCs cultured in control medium (Control), treated with 100 mM
ethanol (EtOH) or 10 μM tBHQ (tBHQ) alone, or treated with both ethanol and tBHQ
(EtOH + tBHQ). Data are expressed as fold change over control and represent the mean ±
SEM of three separate experiments. *p<0.05 vs. control # p< 0.05 vs. EtOH.
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Ethanol and tBHQ exposure increased the activities of the antioxidant enzymes, SOD and
catalase, in NCCs. Cell lysates were prepared from NCCs cultured in control medium
(Control), treated with 100 mM ethanol (EtOH) or 10 μM tBHQ (tBHQ) alone, or treated
with both ethanol and tBHQ (EtOH + tBHQ). Data represent the mean ± SEM of three
separate experiments. *p < 0.05 vs. control. # p< 0.05 vs. EtOH.
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tBHQ treatment significantly reduced ROS generation in ethanol-exposed NCCs. ROS
generation was measured in NCCs cultured in control medium (Control), treated with 100
mM ethanol (EtOH) or 10 μM tBHQ (tBHQ) alone, or treated with both ethanol and tBHQ
(EtOH + tBHQ). Data are expressed as relative fluorescence intensity units and represent the
mean ± SEM of three separate experiments. *p<0.05 vs. control. # p<0.05 vs. EtOH.
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Flow cytometry of apoptotic NCCs with Annexin V-FITC showed that tBHQ treatment
significantly prevents ethanol-induced apoptosis. Apoptosis was measured in NCCs cultured
in control medium (Control), treated with 100 mM ethanol (EtOH) or 10 μM tBHQ (tBHQ)
alone, or treated with both ethanol and tBHQ (EtOH + tBHQ). Data are expressed as fold
change over control and represent the Mean ± SEM of three separate experiments. *p< 0.05
vs. control. # p< 0.05 vs. EtOH.
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